Chafika Mazouni
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 57
- Cancer Genomics and Diagnostics 9
- Oncology top 1%
- HER2/EGFR in Cancer Research 19
- Obstetrics and Gynecology top 1%
- Maternal and Perinatal Health Interventions 10
-
- Breast Lesions and Carcinomas 23
-
- Breast Implant and Reconstruction 25
- Reconstructive Surgery and Microvascular Techniques 12
-
- Pelvic floor disorders treatments 8
- Co-authors
- W. Fraser SymmansFabrice AndréLajos PusztaiGabriel N. HortobágyiAna M. González-AnguloJaime MejiaMarjorie GreenCornelia Liedtke
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Chafika Mazouni
122 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 2.5k
- Oncology 2.3k
- Obstetrics and Gynecology 550
- Pathology and Forensic Medicine 877
- Pediatrics, Perinatology and Child Health 440
Countries citing papers authored by Chafika Mazouni
This map shows the geographic impact of Chafika Mazouni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chafika Mazouni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chafika Mazouni more than expected).
Fields of papers citing papers by Chafika Mazouni
This network shows the impact of papers produced by Chafika Mazouni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chafika Mazouni. The network helps show where Chafika Mazouni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chafika Mazouni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 62 | |
| 3 | 2022 | 1 | |
| 4 | 2018 | 1 | |
| 5 | 2017 | 9 | |
| 6 | 2017 | 31 | |
| 7 | 2015 | 21 | |
| 8 | 2015 | 8 | |
| 9 | 2014 | 15 | |
| 10 | 2014 | 59 | |
| 11 | 2011 | 1 | |
| 12 | 2010 | 41 | |
| 13 | 2008 | 13 | |
| 14 | 2008 | 89 | |
| 15 | 2007 | 100 | |
| 16 | Vav3, a Rho GTPase guanine nucleotide exchange factor, represents a potential novel therapeutic target for breast cancer | 2007 | 1 |
| 17 | 2007 | 3 | |
| 18 | 2006 | 39 | |
| 19 | 2005 | 18 | |
| 20 | 2004 | 4 |
About Chafika Mazouni
Chafika Mazouni is a scholar working on Cancer Research, Obstetrics and Gynecology, Oncology, Pathology and Forensic Medicine and Surgery, having authored 124 papers that have together received 5.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (57 papers), Breast Implant and Reconstruction (25 papers), Breast Lesions and Carcinomas (23 papers), HER2/EGFR in Cancer Research (19 papers), Reconstructive Surgery and Microvascular Techniques (12 papers), Maternal and Perinatal Health Interventions (10 papers), Cancer Genomics and Diagnostics (9 papers) and Pelvic floor disorders treatments (8 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (2.3k citations), Obstetrics and Gynecology (550 citations), Pathology and Forensic Medicine (877 citations) and Pediatrics, Perinatology and Child Health (440 citations). Chafika Mazouni has collaborated with scholars based in France, United States and Germany. Frequent co-authors include W. Fraser Symmans, Fabrice André, Lajos Pusztai, Gabriel N. Hortobágyi, Ana M. González-Angulo, Jaime Mejia, Marjorie Green, Cornelia Liedtke, Massimo Cristofanilli and Bryan T. Hennessy. Their work appears in journals such as European Journal of Cancer, The Breast, Annals of Oncology, Acta Obstetricia Et Gynecologica Scandinavica and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.